Sidoti Estimates Hawkins’ Q4 Earnings (NASDAQ:HWKN)

Hawkins, Inc. (NASDAQ:HWKN) – Investment analysts at Sidoti reduced their Q4 2028 earnings estimates for Hawkins in a research report issued to clients and investors on Tuesday, August 4th. Sidoti analyst D. Harriman now expects that the specialty chemicals company will post earnings per share of $1.02 for the quarter, down from their prior estimate of $1.25. The consensus estimate for Hawkins’ current full-year earnings is $4.04 per share.

Hawkins (NASDAQ:HWKN) last issued its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing the consensus estimate of $1.39 by ($0.04). Hawkins had a return on equity of 15.42% and a net margin of 7.29%.The business had revenue of $315.68 million for the quarter, compared to analysts’ expectations of $313.42 million.

Several other equities analysts also recently weighed in on HWKN. Zacks Research downgraded shares of Hawkins from a “hold” rating to a “strong sell” rating in a report on Tuesday. BWS Financial restated a “buy” rating and set a $200.00 price objective on shares of Hawkins in a research report on Monday. Barclays set a $142.00 target price on shares of Hawkins and gave the company an “equal weight” rating in a research note on Friday, July 31st. Finally, Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $171.00.

Hawkins Stock Up 1.2%

NASDAQ HWKN opened at $135.29 on Thursday. Hawkins has a 52 week low of $117.98 and a 52 week high of $186.15. The company has a quick ratio of 1.54, a current ratio of 2.27 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $2.82 billion, a P/E ratio of 35.05, a price-to-earnings-growth ratio of 2.54 and a beta of 0.79. The stock’s 50-day moving average price is $147.18 and its 200-day moving average price is $149.48.

Hawkins Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Friday, August 14th will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, August 14th. Hawkins’s dividend payout ratio (DPR) is 20.73%.

Hedge Funds Weigh In On Hawkins

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in Hawkins by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,525,789 shares of the specialty chemicals company’s stock valued at $216,754,000 after acquiring an additional 20,958 shares during the last quarter. State Street Corp boosted its holdings in shares of Hawkins by 11.6% during the 4th quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company’s stock valued at $151,642,000 after purchasing an additional 111,318 shares during the last quarter. Wasatch Advisors LP boosted its holdings in shares of Hawkins by 31.4% during the 4th quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company’s stock valued at $78,477,000 after purchasing an additional 131,850 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Hawkins by 2.8% during the fourth quarter. Geode Capital Management LLC now owns 513,535 shares of the specialty chemicals company’s stock valued at $72,965,000 after purchasing an additional 13,828 shares in the last quarter. Finally, Capital World Investors grew its position in shares of Hawkins by 34.4% during the fourth quarter. Capital World Investors now owns 477,985 shares of the specialty chemicals company’s stock valued at $67,903,000 after purchasing an additional 122,366 shares in the last quarter. Hedge funds and other institutional investors own 69.71% of the company’s stock.

More Hawkins News

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Sidoti raised its Q2 2027 EPS estimate to $1.26 from $1.25, and increased its Q1 2028 forecast to $1.57 from $1.55. The firm also lifted its Q2 2028 estimate to $1.48 from $1.45.
• Neutral Sentiment: Sidoti currently projects FY2027 EPS of $4.20 and FY2028 EPS of $5.00. These forecasts provide a benchmark for future performance, but the estimates remain subject to changes in specialty-chemical demand, pricing and operating costs.
• Negative Sentiment: Sidoti cut its FY2027 EPS estimate to $4.20 from $4.45 and reduced its FY2028 forecast to $5.00 from $5.35. The firm also lowered estimates for Q3 2027 to $0.76 from $0.90, Q4 2027 to $0.82 from $0.95, Q3 2028 to $0.93 from $1.10 and Q4 2028 to $1.02 from $1.25.
• Negative Sentiment: The revisions follow Hawkins’ latest quarterly report, in which EPS of $1.35 missed the $1.39 consensus estimate, although revenue exceeded expectations. With the stock trading below its 50-day and 200-day moving averages and carrying a relatively elevated P/E ratio near 35, downward earnings revisions could limit enthusiasm despite the modest positive quarterly changes.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.